Key | % Net Assets |
---|---|
![]() |
4.6% |
![]() |
4.5% |
![]() |
4.3% |
![]() |
4.2% |
![]() |
82.4% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 4.6% |
Standard Life Investments UK Equity Unconstrained Class I | 4.5% |
Vodafone Group | 4.3% |
BP | 4.2% |
Vodafone Group | 4.2% |
British American Tobacco | 3.4% |
Aberforth UK Small Companies | 3.2% |
HSBC Holdings PLC (UK Reg) | 2.9% |
BG Group | 2.3% |
AstraZeneca | 2.3% |
No asset data available.
Date | 14-Feb-2025 |
---|---|
NAV | 200.40p |
Currency | GBP |
Change | 0.70p |
% | 0.35% |
YTD change | 10.30p |
YTD % | 5.42% |
Fund Inception | 28/02/1997 |
---|---|
Fund Manager | HSBC Multimanager |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research